PharmTech LCGC Sciex Webinar 11.10
|Articles|July 1, 2008

Agilent Technologies and BIA Separations GmbH Sign Agreement

Agilent Technologies (Santa Clara, California) and BIA Separations GmbH (Klagenfurt, Austria) have signed an agreement that gives Agilent access to the monolithic column technology developed by BIA Separations GmbH.

Agilent Technologies (Santa Clara, California) and BIA Separations GmbH (Klagenfurt, Austria) have signed an agreement that gives Agilent access to the monolithic column technology developed by BIA Separations GmbH. Agilent plans to commercialize analytical high performance liquid chromatography (HPLC) biomonolith columns with strong and weak anion exchange phases and a Protein A phase. BIA Separations' preparative-scale CIM disks and process-scale CIM tube biomonolithic products are designed for the purification and bioconversion of biomolecules.


Related to this article

Best of the Week: From Cancer Diagnostics to Smarter LC Method Development
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.